233
Views
69
CrossRef citations to date
0
Altmetric
Research Article

ATM Mutations in Sporadic Lymphoid Tumours

, , , , &
Pages 1563-1571 | Published online: 01 Jul 2009

  • Taylor, A.M.R., Metcalfe, J.A., Thick, J. and Mak, Y.-F. (1996) "Leukaemia and lympboma in ataxia telangiectasia". Blood 87, 423-438.
  • Siankoviv, T., Kidd, A.M.J., Sutcliffe, A., et al., (1998) "ATM mutations and phenotypcs in A-T families in the British Isles: expression of mutant ATM and the risk of leukaemia, lymphoma and breast cancer". Am. J. Hum. Genet. 62, 334-345.
  • Savitsky, K. Bar-Shira, A. Gilad, S. et al, (1995) "A single ataxia telangicctasia gene with a product similar to PI-3 kinase". Science 268, 1740-1753.
  • Shiloh, Y. (1997) "Alaxia-lelangiectasiaand the Nijmegan breakage syndrome: related disorders but genes apart", Annu. Rev Genet. 31, 635-662.
  • Shiloh, Y. (2001) "ATM and ATR: net working cellular responses to DNA damage", Curr. Opin. Genet. Dev. 11, 71-77.
  • Vanasse, G.J., Concannon, P. and Willerford, DM. (1999) "Regulated genomic instability and neoplnsia in the lymphoid lineage". Blood 94, 3997-4010.
  • Pekarsky, Y., Hallas, C. and Croce, C.M. (2001) "Molecular basis of mature T-cell leukemia", JAMA 286, 2308-2314.
  • Vorechovsky, I. Luo, L., Dyer, M.J.S., et al, (1997) "Clustering of missense mutations in the ataxia telangieclasia gene in a sporadic T cell leukaemia", Nat. Genet. 17, 96-99.
  • Stiigenbauer, S., Schaffner. C. Litterst, A. et al., (1997) "Biallelic mutations in the ATM gene in T-prolymphocytic leukaemia", Nat. Med. 3, 1155-1159.
  • Stoppa-Lyonnet, D. Soulier, J., Lauge, A. et al. (1998) "Inactivatton of the ATM gene in T-cell prolymphocytic leukaemia", Blood 91, 3920-3926.
  • Bannetji, R. and Byrd, J.C. (2000) "Update on the biology of chronic lymphocytic leukaemia". Curr. Opin, Oncol. 12, 22-29.
  • Caligaris, C.F. (2000) "Biology of chronic lymphocytic leukaemia". Rev. Clin. Exp. Haematol. 4, 5-21.
  • Stilgenbauer, S., Lichter, P. and Dohner, H. (2000) "Genetic features of B-cell chronic lymphocytic leukaemia", Clin. Exp. Haematol. 4, 48-72.
  • Stankovic, T, Weber, P. Stewart, G. et al. (1999) "Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia". Lancet 353, 26-29.
  • Stankovicb T. Stewarl, G.S. Feganb C. Biggs, P., Last, J., Byrdb P.J. Keenan, R.D. Moss, P.A. and Taylor, A.M. (2002) "ATM deficient B-CLL occurs in pre-germinal centre cells results in defective damage response and unrepaired chromosome damage", Blood 99, 300-309.
  • Sandoval, N. Platzer. M., Rosenthal, A. et al. (1999) "Characterization of ATM gene mutations in 66 ataxia telangiectasia families". Hum. Mol. Genet. 1, 69-79.
  • Cook, G.P. and Tomlinson, J.M. (1995) "The human immunoglobulin VH repertoire", Immunol. Today 16, 237-242.
  • Matsuda, E, Shin, EX., Nagaolca, H., et al. (1993) "Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus", Nat. Genet. 3, 88-94.
  • Berek, C. and Millstein, C. (1987) "Mutation drift and repertoire shift in the maturation of the immune response", lmmtmol. Rev 96, 23-41.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmulated Ig VH genes are associated with a moreaggressive form of chronic lymphocytic leukaemia". Blood 94, 1848-1854.
  • Damle, R.N., Wasil, T., Fais, F., et al. (1999) "Ig V gene mutation status and CD38 expression as noel prognostic indicators in chroniclymphocytic leukaemia", Blood 94, 1840-1847.
  • Bullrich, F., Rasio, D., Kitada, S., et al. (1999) "ATM mutations in B-cell chronic lymphocytic leukemia". Cancer Res. 59, 24-27.
  • Schaffner. C., Stilgenbauer, S. Rappold, G.A. Dohner, H. and Lichter, P (1999) "Somutic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia", Blood 94, 748-753.
  • Tolksdorf, G., Stein, H. and Lennert, K. (1980) "Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (cenlrocytes)", Br. J. Cancer 41, 168-182.
  • Weisenburger, D.D. and Armitage, J.O. (1996) "Mantle cell lymphoma--an entity comes of age". Blood 87, 4483-4494.
  • Tsujimoto, Y, Jaffe, E., Cossman, J. Gorham, J. Nowell, P.C. and Croce, C.M. (1985) "Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11; 14) chromosome translocation". Nature 315, 340-343.
  • Stilgenbauer, S., Winkler, D. Ott, G., Schaffner, C. Leupolt, E. Bentz, M., Moller, P. Mullcr-Hermelink, H.K., James, M.R., Lichter, P. and Uohner, H. (1999) "Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in matle cell lymphoma". Blood 94, 3262-3264.
  • Schaffner, C. Idler, I. Slitgenbaue, S. Dohner, H. and Lichter, P. (2000) "Mantle cell lymphoma is characterised by inactivation of the ATM gene", Proc. Natl Acad. Sci. USA 97, 2773-2778.
  • Camacho, E., Hemandez, L. Hernadez, S. Tort, R, Bellosillo, B. Bea, S., Bosch, E. Montscrrat, E. Cardesa, A. Fernandez, P.L. and Campo, E. (2002) "ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances". Blood 99, 238-244.
  • Stoppa-Lyonnct, D. Lauge, A., Sigaux, F. and Stern, M.H. (2000) "No germline ATM mutation in a series of 16 T-cell prolymphocytic leukemias", Blood 96, 374-376.
  • Stankovic, T. Taylor, A.M.R., Yuille, Martin and Vorechovsky, Igor (2001) "Recurrent ATM mutations in T-PLL on diverse haplotypes: no support for their germline origin", Blood 97, 1517-1518.
  • Ponder, B.A.J. (2001) "Cancer genetics". Nat. Rev. 411, 336-341.
  • Bevan, S. Catovsky, D. Marossy, A., et al. (1999) "Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia". Leukemia 10, 1497-1500.
  • Morrell, D., Chase, C.L. and Swift, M. (1990) "Cancers in 44 families with ataxia telangiectasia". Cancer Genet. Cytogcnet, 50, 119-123.
  • Olsen, J.H. Hahnemann, J.M. Borresen-Dale, A.L., et al., (2001) "Cancer in patients with ataxia-telangieclasia and in their relatives in the nordic countries", J. Noll Cancer Inst. 93, 121-127.
  • Geoffroy-Perez, B. Janin, N. Ossian, K. et al. (2001) "Cancer risk in heterozygotes for ataxia-telangiectasia". Int. J. Cancer 93, 288-293.
  • Inskip, H.M., Kinlen, L.J. Taylor, A.M. Woods, C.G. and Arlett, C.F. (1999) "Risk of breast cancer and other cancers in heterozygotes for alaxia-telangiectasia". Br. J. Cancer 79, 1304-1307.
  • Kastan, M.B. and Lin, D. (2000) "The many substrates and functions of ATM", Nature 1, 179-186.
  • Caspari, T. (2000) "How io activate p53". Curr. Biol. 10, R315-R3I7.
  • Linger, T., Sionov, R.V., Moallem, E. et al. (1999) "Mutations in serines 15 and 20 of human p53 impair its apoptotic activity", Oncogens 18, 3205- 3212.
  • Wu, G.S. Burns, T.F. McDonald, ID. E.R., et al., (1999) "Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest". Oncogene 18, 6411-6418.
  • Khanna, K.K. and Jackson, S.P. (2001) "DNA double strand breaks: signalling, repair and cancer connection". Nat. Genet. 27, 247-254.
  • Morrison, C., Sunoda, E. Takao, N. Shinohara, A. Yamamoto, K. and Takeda, S. (2000) "The controlling role of ATM in homologousrecombioational repair of DNA damage". EMBO J. 19, 463-471.
  • Luo, C.M. Tang, W., Mekeel, K.L. DeFrank, J.S., Anne, P.R. and Powell. S.N. (1996) "High frequency and error-prone DNA recombination in ataxia telangiectasia cell lines", J. Biol. Chem. 271, 4497-4503.
  • Pettilt, A.R. Sherrington, P.D., Stewart, G.S. Cawley, J.C., Taylor, A.M.R. and Stankovic, T. (2001) "p53 dysfunction in B-cell chronic lymphocytic leukaemia: inactivation of ATM as an alternative to TP53 mutation". Blood 98, 814-822.
  • Starostik, P. Manshouri, T. O'Brien, S., et al. (1998) "Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia", Cancer Res. 58, 4552-4557.
  • Cordone, I., Masi, S., Mauro, F.R., et al. (1998) "p53 expression in B cell chronic lymphocytic leukaemia: a marker of disease progression and poor prognosis". Blood 91, 4342-4349.
  • Lens, D. Dyer, M.J.S. Garcia-Marco, J.M. et al., (1997) "p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis". Br. J. Haemalol. 99, 848-857.
  • Kleihues, P. Schauble, B. zur Hausen, A. Esieve, J. and Ohgaki, H. (1997) 'Tumors associated with p53 germline mutations: a synopsis of 91 families". Am. J. Pathol. 150, 1-13.
  • Jchikawa, A., Kinoshita, T. Watanabe, T., et al., (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma", N. Engl. J. Med. 337, 529-534.
  • Hupp, T.R. Lane, D.P. and Ball, K.L. (2000) "Strategies for manipulating the p53 pathway in the treatment of human cancer", Biochem. J. 352, 1-17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.